CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
by whole-body PET-CT imaging in participants with convalescent COVID-19. Up to 80 participants will be enrolled over an accrual per...
Phase 2
San Francisco, California, United States
a completed primary series and bivalent booster of mRNA based COVID-19 vaccine and have =\<2500 U/mL SARS-CoV-2 S antibody concentr...
Phase 2
San Francisco, California, United States and 5 other locations
This study is to learn about flu and COVID vaccines, either alone or when mixed together. Healthy people aged 18 or older can join. Participants will...
Phase 1, Phase 2
Walnut Creek, Colorado, United States of America and 21 other locations
The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together.This study is seeking healthy...
Phase 1, Phase 2
Walnut Creek, Colorado, United States of America and 11 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
San Francisco, California, United States and 59 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 2, Phase 3
Oakland, California, United States and 114 other locations
the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...
Phase 4
Palo Alto, California, United States and 31 other locations
This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...
Phase 2, Phase 3
Walnut Creek, California, United States and 94 other locations
, * who previously received at least 3 doses of a US-authorized mRNA COVID-19 vaccine, with the most recent dose being an Omicron ...
Phase 2, Phase 3
Walnut Creek, Colorado, United States of America and 40 other locations
This study will enroll individuals who have:* Completed primary series of mRNA COVID-19 vaccine, and* An antibody response ≤ 2500 U-...
Phase 2
San Francisco, California, United States and 14 other locations
Clinical trials
Research sites
Resources
Legal